We are live on
!
Find out more
SPA
Sherbrooke Park Advisers Portfolio holdings
AUM
$38.7M
1-Year Est. Return
5.29%
This Fund
S&P 500
This Quarter
Est. Return
+1.77%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$301M
(+141%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
57.02%
Top 10 Holdings %
Top 10 Hldgs %
5.45%
Holding
1,025
New
585
Increased
167
Reduced
66
Closed
207
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SSR Mining
SSRM
|
+$4.08M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
+$3.92M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
+$2.98M |
| 4 |
Lennar Class A
LEN
|
+$2.74M |
| 5 |
Dow Inc
DOW
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$2.12M |
| 2 |
HOLX
Hologic
HOLX
|
+$2.01M |
| 3 |
Marathon Petroleum
MPC
|
+$1.66M |
| 4 |
Coca-Cola
KO
|
+$1.58M |
| 5 |
Jabil
JBL
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.07% |
| 2 | Industrials | 18.09% |
| 3 | Consumer Discretionary | 13.93% |
| 4 | Healthcare | 10.29% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Lantheus
LNTH
$6.59B
| $480K | 0.09% |
+7,708
| New | +$454K |
|
377
CNO Financial Group
CNO
$5.13B
| $478K | 0.09% |
+17,399
| New | +$470K |
|
378
Automatic Data Processing
ADP
$108B
| $477K | 0.09% |
1,911
-37
| -2% | -$9.04K |
|
379
Toll Brothers
TOL
$14B
| $476K | 0.09% |
+3,680
| New | +$400K |
|
380
UnitedHealth
UNH
$373B
| $475K | 0.09% |
+961
| New | +$489K |
|
381
KKR & Co
KKR
$92.4B
| $472K | 0.09% |
+4,696
| New | +$432K |
|
382
BridgeBio Pharma
BBIO
$16.7B
| $472K | 0.09% |
+15,259
| New | +$519K |
|
|
FFWM
383
DELISTED
First Foundation Inc
FFWM
| $471K | 0.09% |
+62,341
| New | +$534K |
|
384
Par Pacific Holdings
PARR
$3.61B
| $470K | 0.09% |
+12,694
| New | +$466K |
|
385
DocGo
DCGO
$57.3M
| $470K | 0.09% |
+116,342
| New | +$439K |
|
386
Kontoor Brands
KTB
$4.31B
| $470K | 0.09% |
+7,794
| New | +$467K |
|
|
TMHC
387
DELISTED
Taylor Morrison
TMHC
| $468K | 0.09% |
+7,520
| New | +$414K |
|
388
Blackrock
BLK
$175B
| $467K | 0.09% |
+560
| New | +$450K |
|
389
NETGEAR
NTGR
$622M
| $466K | 0.09% |
+29,561
| New | +$430K |
|
390
Castle Biosciences
CSTL
$1B
| $461K | 0.09% |
+20,825
| New | +$453K |
|
391
Itron
ITRI
$4.52B
| $460K | 0.09% |
+4,968
| New | +$400K |
|
392
Murphy Oil
MUR
$5.07B
| $458K | 0.09% |
+10,023
| New | +$404K |
|
393
Montauk Renewables
MNTK
$248M
| $456K | 0.09% |
+109,598
| New | +$687K |
|
394
Labcorp
LH
$25.9B
| $456K | 0.09% |
+2,087
| New | +$460K |
|
395
Urban Edge Properties
UE
$2.72B
| $456K | 0.09% |
+26,395
| New | +$457K |
|
396
Magnite
MGNI
$3.47B
| $455K | 0.09% |
+42,326
| New | +$423K |
|
397
DuPont de Nemours
DD
$19.3B
| $453K | 0.09% |
+4,706
| New | +$419K |
|
|
SNCY
398
DELISTED
Sun Country Airlines
SNCY
| $452K | 0.09% |
+29,979
| New | +$432K |
|
|
CTLP
399
DELISTED
Cantaloupe
CTLP
| $452K | 0.09% |
+70,348
| New | +$464K |
|
400
Carrier Global
CARR
$52.4B
| $452K | 0.09% |
7,780
-4,760
| -38% | -$267K |
|
Similar funds
2C
SIM
ISSM
KCM
EFI
ICM
APM
CI
Sherbrooke Park Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.
- Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
- Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
- Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
- Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
- Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
- Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
- Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.
Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.